NCPA-Supported Bill to Fight Drug Abuse Sent to White House for Enactment
National Community Pharmacists Association CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to passage of S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act, by the U.S. House of Representatives.
PRESS RELEASE
ALEXANDRIA, Va. (April 13, 2016) - National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA, issued the following statement today in response to passage of S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act, by the U.S. House of Representatives:
"NCPA commends Congress for approving this bipartisan legislation, and we look forward to its expected signature into law by President Obama. This legislation advances NCPA's dual aim of reducing prescription drug abuse while ensuring access for patients with legitimate medical need for prescription painkillers. NCPA worked constructively with Congress and stakeholders in the development of this legislation and in particular we appreciate the efforts of Senators Orrin Hatch (R-Utah) and Sheldon Whitehouse (D-R.I.) and Reps. Tom Marino (R-Pa.) and Peter Welch (D-Vt.)."
